NCCN, ESMO and Cancer Australia recognise scalp cooling as standard of care


National Comprehensive Cancer Network® (NCCN)

  • Scalp cooling is a Category 2A recommendation to reduce the incidence of chemotherapy-induced alopecia for patients receiving chemotherapy.
  • For NCCN scalp cooling recommendations view the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)

    – Breast cancer (Version 1.2019) – Category 2A recommendation

    – Ovarian cancer (Version 1.2020) – Category 2A recommendation

European Society for Medical Oncology (ESMO)

Cancer Australia

Please note that the content of this website is not intended as professional medical or healthcare advice and should not be construed as a substitute for professional healthcare advice, or services from a qualified professional healthcare provider familiar with your unique situation. This content is intended solely as a general product and corporate information.

OPERATIONS
Dignitana
10925 Estate Lane, Suite 185
Dallas, TX 75238
+1 877-350-2150

HEADQUARTERS
Dignitana AB
Traktorgränden 3
226 60 Lund, Sweden
+46 46 16 30 90

DISTRIBUTOR
Aurora BioScience
PO Box 946
Baulkham Hills NSW 2153
+61 1300 309 994
+64 0800 533 272